| Q89587434 | Anticoagulant treatment for subsegmental pulmonary embolism |
| Q38214963 | Cancer-associated unsuspected pulmonary embolism |
| Q37204243 | Characteristics and clinical value of 3D MR imaging in the diagnosis of pulmonary embolism |
| Q38382279 | Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program |
| Q89998458 | Incidental pulmonary emboli in stage IV melanoma patients: Prevalence in CT staging examinations and improved detection with vessel reconstructions based on dual energy CT |
| Q36950048 | Is it safe to withhold long-term anticoagulation therapy in patients with small pulmonary emboli diagnosed by SPECT scintigraphy? |
| Q47991267 | Magnetic Resonance Imaging of Pulmonary Embolism: Diagnostic Accuracy of Unenhanced MR and Influence in Mortality Rates |
| Q28071443 | Management of venous thromboembolism: an update |
| Q90727862 | Rates of Overtreatment and Treatment-Related Adverse Effects Among Patients With Subsegmental Pulmonary Embolism |
| Q49989172 | Symptomatic subsegmental pulmonary embolism: to treat or not to treat? |
| Q53089885 | The yield of CT pulmonary angiograms to exclude acute pulmonary embolism. |
| Q30784880 | Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data. |